<?xml version="1.0" encoding="UTF-8"?>
<ref id="B136-molecules-26-03005">
 <label>136.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kuczynski</surname>
    <given-names>E.A.</given-names>
   </name>
   <name>
    <surname>Sargent</surname>
    <given-names>D.J.</given-names>
   </name>
   <name>
    <surname>Grothey</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Kerbel</surname>
    <given-names>R.S.</given-names>
   </name>
  </person-group>
  <article-title>Drug rechallenge and treatment beyond progression-implications for drug resistance</article-title>
  <source>Nat. Rev. Clin. Oncol.</source>
  <year>2013</year>
  <volume>10</volume>
  <fpage>571</fpage>
  <lpage>587</lpage>
  <pub-id pub-id-type="doi">10.1038/nrclinonc.2013.158</pub-id>
  <?supplied-pmid 23999218?>
  <pub-id pub-id-type="pmid">23999218</pub-id>
 </element-citation>
</ref>
